Hemas Holdings Toekomstige groei

Future criteriumcontroles 1/6

De verwachting is dat Hemas Holdings de winst en omzet met respectievelijk 17% en 11.4% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 17.2% per jaar.

Belangrijke informatie

17.0%

Groei van de winst

17.2%

Groei van de winst per aandeel

Industrials winstgroei	13.7%
Inkomstengroei	11.4%
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	Low
Laatst bijgewerkt	19 Sep 2024

Recente toekomstige groei-updates

Recent updates

Winst- en omzetgroeiprognoses

COSE:HHL.N0000 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (LKR Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
3/31/2027	158,350	N/A	N/A	N/A	1
3/31/2026	139,708	8,153	N/A	N/A	2
3/31/2025	128,771	7,196	N/A	N/A	2
9/30/2024	117,051	6,249	4,526	9,267	N/A
6/30/2024	117,969	5,960	9,241	11,916	N/A
3/31/2024	121,614	6,109	11,500	13,906	N/A
12/31/2023	122,383	5,592	10,687	12,491	N/A
9/30/2023	120,930	4,351	7,818	9,453	N/A
6/30/2023	118,220	4,282	-418	1,108	N/A
3/31/2023	113,940	4,269	-10,753	-9,262	N/A
12/31/2022	102,839	4,273	-15,936	-14,634	N/A
9/30/2022	94,614	4,898	-6,275	-4,954	N/A
6/30/2022	87,268	4,691	1,122	2,621	N/A
3/31/2022	78,831	4,249	6,419	8,052	N/A
12/31/2021	74,313	4,033	8,998	10,941	N/A
9/30/2021	70,444	3,794	-328	1,630	N/A
6/30/2021	67,956	4,234	199	2,127	N/A
3/31/2021	64,501	4,058	4,646	6,539	N/A
12/31/2020	61,932	3,655	2,443	4,520	N/A
9/30/2020	61,876	3,245	5,509	7,876	N/A
6/30/2020	59,794	2,245	2,675	5,479	N/A
3/31/2020	60,043	1,357	-1,486	1,589	N/A
12/31/2019	62,076	1,776	-292	2,795	N/A
9/30/2019	62,464	1,846	-1,155	1,788	N/A
6/30/2019	63,775	2,389	-1,412	1,422	N/A
3/31/2019	64,082	3,369	-894	1,813	N/A
12/31/2018	63,055	3,092	210	2,892	N/A
9/30/2018	57,316	2,748	993	3,846	N/A
6/30/2018	52,249	2,548	N/A	4,813	N/A
3/31/2018	49,874	2,687	N/A	5,782	N/A
12/31/2017	46,320	3,186	N/A	2,638	N/A
9/30/2017	45,351	3,368	N/A	2,716	N/A
6/30/2017	44,650	3,489	N/A	2,599	N/A
3/31/2017	43,404	3,491	N/A	3,005	N/A
12/31/2016	41,621	3,152	N/A	2,273	N/A
9/30/2016	40,196	3,147	N/A	2,354	N/A
6/30/2016	39,047	2,935	N/A	3,965	N/A
3/31/2016	37,977	2,653	N/A	4,251	N/A
12/31/2015	37,144	2,681	N/A	4,049	N/A
9/30/2015	35,510	2,276	N/A	3,559	N/A
6/30/2015	34,139	2,236	N/A	3,423	N/A
3/31/2015	32,497	2,122	N/A	3,329	N/A
12/31/2014	31,120	2,806	N/A	2,873	N/A
9/30/2014	30,158	2,733	N/A	2,645	N/A
6/30/2014	28,354	2,595	N/A	2,055	N/A
3/31/2014	27,259	2,571	N/A	2,896	N/A
12/31/2013	26,566	1,707	N/A	3,419	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei HHL.N0000 ( 17% per jaar) ligt boven de spaarquote ( 3.8% ).

Winst versus markt: De winst van HHL.N0000 ( 17% per jaar) zal naar verwachting langzamer groeien dan de markt LK ( 46.3% per jaar).

Hoge groeiwinsten: De winst van HHL.N0000 zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van HHL.N0000 ( 11.4% per jaar) zal naar verwachting langzamer groeien dan de markt LK ( 13.5% per jaar).

Hoge groei-inkomsten: De omzet van HHL.N0000 ( 11.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van HHL.N0000 naar verwachting over 3 jaar hoog zal zijn

Hemas Holdings Toekomstige groei

Future criteriumcontroles 1/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target increased by 7.5% to LK₨105

Price target decreased by 11% to LK₨97.37

Price target increased by 9.3% to LK₨112

Consensus EPS estimates fall by 17%

Price target increased by 9.0% to LK₨78.50

Price target increased to LK₨74.25

Recent updates

First half dividend increased to LK₨1.00

Second quarter 2025 earnings released: EPS: LK₨2.53 (vs LK₨2.04 in 2Q 2024)

Price target increased by 7.5% to LK₨105

First quarter 2025 earnings released: EPS: LK₨1.58 (vs LK₨1.83 in 1Q 2024)

Non-Executive Director recently sold LK₨11m worth of stock

Final dividend increased to LK₨3.00

Hemas Holdings PLC, Annual General Meeting, Jun 27, 2024

Price target decreased by 11% to LK₨97.37

Third quarter 2024 earnings released: EPS: LK₨3.72 (vs LK₨1.64 in 3Q 2023)

Second quarter 2024 earnings released: EPS: LK₨2.04 (vs LK₨1.93 in 2Q 2023)

Upcoming dividend of LK₨0.40 per share at 3.3% yield

Price target increased by 9.3% to LK₨112

Hemas Holdings Announces Resignation of Kasturi Chellaraja, Group CEO

Consensus EPS estimates fall by 17%

First quarter 2024 earnings released: EPS: LK₨1.83 (vs LK₨1.81 in 1Q 2023)

Upcoming dividend of LK₨1.95 per share at 3.4% yield

Hemas Holdings PLC (COSE:HHL.N0000) acquired remaining 24.9% stake in Atlas Axillia Co. (Pvt) Ltd from Nirmal Anrudha Madanayake for LKR 3.4 billion.

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target increased by 9.0% to LK₨78.50

Third quarter 2023 earnings released: EPS: LK₨1.64 (vs LK₨2.69 in 3Q 2022)

Hemas Holdings PLC Announces Board Appointments, Effective January 1, 2023

Hemas Holdings PLC Announces Executive Changes, Effective January 1, 2023

Second quarter 2023 earnings released: EPS: LK₨1.93 (vs LK₨1.58 in 2Q 2022)

Price target increased to LK₨74.25

Consensus revenue estimates increase by 11%

First quarter 2023 earnings released: EPS: LK₨1.81 (vs LK₨1.07 in 1Q 2022)

Upcoming dividend of LK₨1.95 per share

Hemas Holdings PLC, Annual General Meeting, Jun 28, 2022

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to LK₨79.08

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: EPS exceeds analyst expectations

Second quarter 2022 earnings released: EPS LK₨1.58 (vs LK₨2.33 in 2Q 2021)

Upcoming dividend of LK₨2.90 per share

Non-Executive Chairman recently bought LK₨180m worth of stock

Price target decreased to LK₨100

First quarter 2022 earnings released: EPS LK₨1.07 (vs LK₨0.45 in 1Q 2021)

Upcoming dividend of LK₨1.45 per share

Full year 2021 earnings released: EPS LK₨6.81 (vs LK₨2.07 in FY 2020)

Independent Director has left the company

New 90-day low: LK₨80.40

Third quarter 2021 earnings released: EPS LK₨2.30 (vs LK₨1.64 in 3Q 2020)

New 90-day high: LK₨105

New 90-day high: LK₨101

Eden Hotel Lanka PLC (COSE:EDEN.N0000) acquired 56.6% stake in Serendib Hotels PLC (COSE:SHOT.N0000) from Hemas Holdings PLC (COSE:HHL.N0000) for approximately LKR 790 million.

New 90-day high: LK₨90.00

Price target raised to LK₨80.90

New 90-day high: LK₨79.10

Second quarter 2021 earnings released: EPS LK₨2.16

Hemas Holdings PLC Announces Executive Changes

New 90-day high - LK₨65.10

First quarter earnings released

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven